With reference to the discrepancy raised by the Exchange regarding non-submission in PDF for Standalone Financial Results, we hereby submit the Cash Flow Statement for the respective period ....
Awaiting price reaction for this filing.
Nutraplus India Limited, a small-cap API manufacturer, filed its unaudited Q2 and H1 FY26 results after significant delay, along with a separate Cash Flow Statement to address a BSE discrepancy notice. The statutory auditor (Raman S. Shah & Associates) issued a Qualified Limited Review Report, flagging non-compliance with SEBI listing timelines and delayed submission of financial data needed for review. An Emphasis of Matter paragraph highlights that the company lost all its property, plant and equipment under the SARFAESI Act, 2002, after being declared a Non-Performing Asset in FY-19-20, with the bank's auction process delayed due to COVID-19. The balance sheet shows deeply negative net worth of approximately Rs 571.52 crore (worsening from Rs 535.02 crore in March 2025), with borrowings of Rs 845.17 crore against negligible non-current assets of Rs 1.80 crore. The company reported a net loss for the period and negative operating cash flow of about Rs 44.56 crore for H1 FY26.
This is a very negative filing for shareholders. The company has effectively no net worth, has lost all physical assets to lenders, is generating negative operating cash, and now carries a qualified audit opinion citing regulatory non-compliance. The stock is highly risky and existing equity holders face potential total loss.